CDS Glycolic

INCI: AQUA, MANNITOL, PHOSPHATIDYLCHOLINE, GLYCERIN, GLYCOLIC ACID, CHOLESTEROL, POLYSORBATE-80, POTASSIUM SORBATE, SODIUM BENZOATE, CERAMIDE NP (CERAMIDE 3), XANTHAN GUM, SODIUM CHLORIDE

Description

CDS-Glycolic (*Vegan version also available: Vegan CDS-Glycolic)

Superficial Delivery Nanovesicles (CORNEUM DELIVERY SYSTEM) with 3% Glycolic Acid

+260% delivery in the stratum corneum compared to active ingredients without encapsulation.

Up to 15 times greater concentration than other standard liposome products

Accelerates the renewal of the stratum corneum.
Improves the general appearance of the skin.
Adjuvant treatment for dyschromias.
Improves the appearance of fine expression lines.
Facilitates skin hydration

CORNEUM DELIVERY SYSTEM

The active ingredients encapsulated in the “Corneum Delivery” systems are delivered specifically to the most superficial layers of the epidermis, the corneal layer, in order to have the most precise and intense effect at this level.

By using these superficial delivery systems, a far greater concentration of the active ingredient in the corneal layer is achieved, thereby reducing penetration to deeper skin layers. This is very useful in the avoidance of any unwanted effects at these layers, for example, when using active ingredients with a high irritant factor.

The “Corneum Delivery” systems are particularly useful in the encapsulation of alpha hydroxy acids as they enable very low pH levels to be maintained in the interior of the nanovesicles, irrespective of the pH of the medium where they are formulated. Consequently, almost all of the acid concentration of the nanovesicle remains unseparated until its delivery to the corneal layer. This facilitates a reduction in the necessary dosage of AHA and the use of pHs with more physiological formulations.

Furthermore, the phospholipids and ceramides that make up the nanovesicles rapidly repair damage caused by the AHA, recuperating the skin barrier and significantly improving tolerance level

USE LEVEL: 1-10%